Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
412.95
Change Change %
0.15 0.04%

Updated:16 Aug, 2019, 15:59 PM IST

BSE
411.90
Change Change %
-0.75 -0.18%

Updated:16 Aug, 2019, 16:01 PM IST

Strides Arcolab, incorporated in 1990, is engaged in the manufacture of pharmaceutical dosage forms in branded as well generic categories. The dosages are manufactured in form of tablets, capsules, soft gelatin capsules, parenterals and semi–solids.

The company manufactures soft gels and steriles. It has 13 manufacturing facilities located across the world –– in India, Singapore, Brazil, Mexico, Poland and Italy.

These facilities have received approval from various regulatory authorities namely MHHRA, TGA, MCC, ANVISA. The company?óÔé¼Ôäós Bangalore plant is pre–qualified by WHO to manufacture of HIV/ AIDS and anti–TB drugs.

The company is among the top 5 soft gelatin capsule manufacturers in world.

Strides Acrolab has partnered with major pharmaceutical companies located in Australia, South Africa, Europe, and USA.

The company has a joint venture with Akorn –– Akorn–Strides, LLC –– to develop liquid, lyophilized and dry powder formulations of generic injectable products targeting several therapeutic markets.

Products

Soft gel capsules– The company manufactures range of soft gel in category of nutraceuticals, Rx, specialty OTCs and immunosuppressants.

Steriles– Under this, it offers its products in therapeutic segments that includes beta–lactams and cephalosporins. The company manufactures striles in various forms such as prefill syringes, ampoules, vials and penicillins.

Outlook

Akorn–Strides, LLC has received approval from the US Food and Drug Administration for two Abbreviated New Drug Applications (ANDAs) for Sterile Vancomycin HCl USP, 500 mg/vial, 1 g/vial and Sterile Vancomycin HCl USP, 5 g/vial Pharmacy Bulk Package.

Top